D.E. Shaw & Co’s Forbion European Acquisition Corp. Class A Ordinary Shares FRBN Stock Holding History

D.E. Shaw & Co’s Portfolio FRBN Stock Details FRBN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-320,688	Closed	-$3.54M	–	4774
2023 Q3	$3.54M	Hold	320,688	–	–	﹤0.01%	2129
2023 Q2	$3.44M	Buy	320,688 +6,522	+2%	+$69.1K	﹤0.01%	2168
2023 Q1	$3.31M	Hold	314,166	–	–	﹤0.01%	2300
2022 Q4	$3.25M	Hold	314,166	–	–	﹤0.01%	2514
2022 Q3	$3.18M	Hold	314,166	–	–	﹤0.01%	2574
2022 Q2	$3.14M	Buy	314,166 +247,500	+371%	+$2.47M	﹤0.01%	2657
2022 Q1	$665K	Buy	+66,666	New	+$661K	﹤0.01%	4196

D.E. Shaw & Co's FRBN Position: Q4 2023 in Review

D.E. Shaw & Co sold out of Forbion European Acquisition Corp. Class A Ordinary Shares (FRBN) in Q4 2023, closing a stake of 320,688 shares — an estimated $3.54M sold.

D.E. Shaw & Co first reported a position in FRBN in Q1 2022 and held it in 7 quarters. The position peaked at $3.54M in Q3 2023. 0 funds tracked by Wall St. Rank hold FRBN as of Q4 2023.

D.E. Shaw & Co reported no remaining Forbion European Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
D.E. Shaw & Co sold 320,688 Forbion European Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $3.54M.
D.E. Shaw & Co first reported a position in Forbion European Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 7 quarters.
D.E. Shaw & Co's Forbion European Acquisition Corp. Class A Ordinary Shares position peaked at $3.54M in Q3 2023.
0 funds tracked by Wall St. Rank held Forbion European Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.